FI882018A - Method for selective immunologic determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids and agents for carrying out this - Google Patents

Method for selective immunologic determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids and agents for carrying out this Download PDF

Info

Publication number
FI882018A
FI882018A FI882018A FI882018A FI882018A FI 882018 A FI882018 A FI 882018A FI 882018 A FI882018 A FI 882018A FI 882018 A FI882018 A FI 882018A FI 882018 A FI882018 A FI 882018A
Authority
FI
Finland
Prior art keywords
type iii
procollagen
body fluids
selective
agents
Prior art date
Application number
FI882018A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI95579B (en
FI882018A0 (en
FI95579C (en
Inventor
Dietrich Brocks
Rubert Timpl
Original Assignee
Hoechst Ag
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag, Max Planck Gesellschaft filed Critical Hoechst Ag
Publication of FI882018A0 publication Critical patent/FI882018A0/en
Publication of FI882018A publication Critical patent/FI882018A/en
Publication of FI95579B publication Critical patent/FI95579B/en
Application granted granted Critical
Publication of FI95579C publication Critical patent/FI95579C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lifting Devices For Agricultural Implements (AREA)
  • Tires In General (AREA)
  • Agricultural Machines (AREA)

Abstract

It is possible by immunising animals with a peptide of the sequence I-C-E-S-C-P-T-G-G-Q-N-Y-S-P bound to an immunogenic protein to raise antibodies which can be used to determine procollagen peptide (type III) and procollagen type III selectively in body fluids.
FI882018A 1987-05-02 1988-04-29 Method for selective immunologic determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids and agents for carrying out this FI95579C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873714634 DE3714634A1 (en) 1987-05-02 1987-05-02 METHOD FOR SELECTIVE IMMUNOLOGICAL DETERMINATION OF INTACT PROCOLLAGEN PEPTIDE (TYPE III) AND PROCOLLAGEN (TYPE III) IN BODY LIQUIDS AND MEANS TO IMPLEMENT IT
DE3714634 1987-05-02

Publications (4)

Publication Number Publication Date
FI882018A0 FI882018A0 (en) 1988-04-29
FI882018A true FI882018A (en) 1988-11-03
FI95579B FI95579B (en) 1995-11-15
FI95579C FI95579C (en) 1996-02-26

Family

ID=6326686

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882018A FI95579C (en) 1987-05-02 1988-04-29 Method for selective immunologic determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids and agents for carrying out this

Country Status (10)

Country Link
EP (1) EP0298210B1 (en)
JP (1) JPH0780913B2 (en)
AT (1) ATE98377T1 (en)
DE (2) DE3714634A1 (en)
DK (1) DK168872B1 (en)
ES (1) ES2061545T3 (en)
FI (1) FI95579C (en)
IE (1) IE63385B1 (en)
NO (1) NO175639C (en)
PT (1) PT87375B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6010862A (en) * 1987-11-06 2000-01-04 Washington Research Foundation Methods of detecting collagen type III degradation in vivo
DE4225038C2 (en) * 1992-07-29 1995-11-30 Boehringer Mannheim Gmbh Production and use of antibodies against collagen
CA2167496A1 (en) * 1993-07-28 1995-02-09 Werner Naser Immunoassay for the detection of collagen or collagen fragments
GB9506050D0 (en) 1995-03-24 1995-05-10 Osteometer A S Assaying collagen fragments in body fluids
EP0787301B1 (en) 1994-10-17 2001-02-14 Osteometer Biotech AS Estimation of the fragmentation pattern of collagen in body fluids and the diagnosis of disorders associated with the metabolism of collagen
US6107047A (en) * 1996-03-21 2000-08-22 Osteometer Biotech A/S Assaying protein fragments in body fluids
GB9617616D0 (en) 1996-08-22 1996-10-02 Osteometer Biotech As Assaying protein fragments in body fluids
WO1998026286A2 (en) 1996-12-09 1998-06-18 Osteometer Biotech A/S Sandwich assays for collagen type i fragments
US6117646A (en) * 1997-09-22 2000-09-12 Osteometer Biotech A/S Assaying protein fragments in body fluids
DE69915059T2 (en) * 1998-05-28 2004-08-26 Bayer Healthcare Ag MONOCLONAL ANTIBODY AND ASSAY FOR DETERMINING N-TERMINAL PROCOLLAGEN PROPEPTIDE TYPE III (PIIINP)
US6916903B2 (en) 1998-06-19 2005-07-12 Washington Research Foundation Collagen type III synthetic peptides for collagen resorption assays
US6602980B1 (en) 1998-06-19 2003-08-05 Washington Research Foundation Collagen type III synthetic peptides for collagen resorption assays

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2816841A1 (en) * 1978-04-18 1979-10-31 Max Planck Gesellschaft RADIOIMMUNOLOGICAL DETERMINATION OF PROCOLLAGEN (TYPE III) AND PROCOLLAGEN PEPTIDE (TYPE III)
DE3209149A1 (en) * 1982-03-13 1983-10-06 Hoechst Ag METHOD FOR THE COMMON IMMUNOLOGICAL DETERMINATION OF PROCOLLAGEN PEPTIDE (TYPE III) AND PROCOLLAGEN PEPTIDE COL 1 (TYPE III) AND METHOD FOR THE PRODUCTION OF ANTI-PROCOLLAGEN PEPTIDE COL 1 (TYPE III) SERUM

Also Published As

Publication number Publication date
EP0298210A2 (en) 1989-01-11
ATE98377T1 (en) 1993-12-15
JPH0780913B2 (en) 1995-08-30
DK168872B1 (en) 1994-06-27
FI95579B (en) 1995-11-15
IE881289L (en) 1988-11-02
JPS63292061A (en) 1988-11-29
NO175639B (en) 1994-08-01
EP0298210B1 (en) 1993-12-08
PT87375A (en) 1989-05-31
DE3886109D1 (en) 1994-01-20
NO881904L (en) 1988-11-03
FI882018A0 (en) 1988-04-29
ES2061545T3 (en) 1994-12-16
DK232988A (en) 1988-11-03
NO881904D0 (en) 1988-04-29
EP0298210A3 (en) 1991-05-15
PT87375B (en) 1992-08-31
FI95579C (en) 1996-02-26
DE3714634A1 (en) 1988-11-17
NO175639C (en) 1994-11-09
IE63385B1 (en) 1995-04-19
DK232988D0 (en) 1988-04-28

Similar Documents

Publication Publication Date Title
FI882018A0 (en) Method for selective immunologic determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids and agents for carrying out this
FI864427A0 (en) Process for producing a polypeptide complementary to at least a portion of an original peptide or protein and utilizing the complementary polypeptide
FI885543A0 (en) DNA SEGMENT, POLYPEPTIDER OTI ANTI-CROPPAR ANSLUTANDE TILL HUMAN VAEVNADSFAKTOR.
ES521418A0 (en) PROCEDURE FOR THE PREPARATION OF FUNCTIONAL PROTEINS OF HUMAN UROKINASE.
DE3684078D1 (en) CLEANING AND ACTIVATION OF PROTEINS FROM INSOLUBLE INCLUDING BODIES.
ATE355371T1 (en) PROTEIN HAVING AN ACTIVITY OF SUPPRESSING AGING
DE59207351D1 (en) Improved activation of recombinant proteins
ATE113960T1 (en) PROTEIN RECOVERY.
ES2075465T3 (en) ADMINISTRATION OF COMPOUNDS TO AQUATIC ANIMALS CARRIED OUT THROUGH ULTRASONICS.
SE8604270D0 (en) KATS INCLUDING POLYPEPTIDE CONTAINED IN PANCREASOAMYLOID AND / OR ANTIBODIES TARGETED TO THE POLYPEPTIDE, AND THE USE OF THE KIT
FI93842B (en) Process for renaturation of proteins
DK218582A (en) PROCEDURE FOR CLEANING UNLESS ENJOYMENT OF BIOLOGICAL ACTIVE PROTEINS AND SUITABLE AGENTS
NO903681D0 (en) MONOCLONAL ANTIBODIES AGAINST ACTIVATED RACE PROTEINS WITH AMINO ACID MUTIONS IN POSITION 13 IN THE PROTEIN.
PT81253A (en) SYNTHETIC SIGNAL SEQUENCE FOR THE TRANSPORT OF PROTEINS IN EXPRESSION SYSTEMS
DE3873273D1 (en) METHOD FOR SELECTIVE CLEAVAGE OF FUSION PROTEINS.
ATE89862T1 (en) MONOCLONAL ANTIBODIES FOR THE SELECTIVE IMMUNOLOGICAL DETERMINATION OF INTACT PROCOLLAGEN PEPTIDE (TYPE III) AND PROCOLLAGEN (TYPE III) IN BODY FLUID.
山田隆紹 et al. Immunoglobulin compositions of the feline body fluids.
DE69513226D1 (en) Use of azoles as virus-killing substances in solutions of biologically active proteins
FI885025A (en) KOAGULATIONSHAEMMANDE PROTEIN PP4-X, DESS FRAMSTAELLNING OCH ANVAENDNING.
SE8504371L (en) ALCOHOLIC DRINKS WITH HIGH PROTEIN AND PROCEDURES FOR PRODUCING THEREOF
KR880006359A (en) Uniform amount TIITS and its use as intermediates for the manufacture of human TIITS
UA19904A1 (en) METHOD OF OBTAINING ANTI-VARIAL CYTOTOXIC SERUM SPECIFIC TO COWS

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT

Owner name: MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENS